Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112824421A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.